Skip to main content
. 2020 Apr 29;12(5):1117. doi: 10.3390/cancers12051117

Figure 5.

Figure 5

Celecoxib is not a Pgp inhibitor and does not increase the toxicity of DOX. (a) In contrast to verapamil (blue), a known Pgp inhibitor, 16–160 µM CEL (green) does not inhibit the function of Pgp. (b,c) CEL does not show synergistic toxicity with DOX in P388 (b) or in CLBL-1 (c) cells. (d,e) Effect of CEL treatment on MDR in Pgp-expressing P388/ADR (d) and CLBL-1 D (e). CEL treatment resulted in a more pronounced reduction of MAF in Pgp-expressing P388/ADR (d) and CLBL-1 D (e) cells than drug holiday (DH).